Most people considering surgical hair restoration are unaware of the scope and possible pitfalls of this medical specialty. While some perspective patients may understand the basic science behind these procedures, few have any grasp of the aesthetics and artistry required to perform them well. Unfortunately, many of the physicians who perform these procedures are as ill informed as their patients.
Flashy marketing and high-pressure sales pitches dominate the field, making truly objective and rational decision making by the patient nearly impossible. In general, hair transplantation is not handled as the medical specialty that it is, one that serves patients, but rather as a business that serves consumers.
With that said, The American Hair loss Association fully endorses surgical hair restoration for those candidates who can benefit from the procedure. It is important to note, however, that there are only a handful of qualified surgeons and surgical staffs performing hair restoration surgery in the US and worldwide. In this section you will learn what questions to ask during your consults, as well as what to look for and what to avoid when choosing a hair restoration surgeon.
The donated hair follicles, surrounding tissue and skin are called grafts . Each graft contains one or more hair follicles with accompanying hair, tissue, and skin.
The art of hair transplantation is as important as the mechanics of this medical technique. It is important to remember that no two heads are alike, and each procedure should be looked at on an individual basis. Hair density is the number of hair follicles per squared centimeter of scalp. Scalp laxity constitutes the flexibility or looseness of the scalp, the more flexible your scalp, the easier it is to harvest donor follicles . Conversely, the tighter the scalp the more difficult it is not only to harvest donor hair, but also to close the donor area after excision. More hair can be transplanted if the scalp is loose and the density is high.
Hair grows in several different directions from the scalp ; forward at the top and front, down or away from the middle and the sides of the head, and back or down in the rear.
Coarse Hair has naturally greater bulk, therefore covering more surface area and can be transplanted using fewer grafts. Fine hair obviously has less bulk, consequently providing less coverage on the scalp than coarser hair . More grafts will be required to create a fuller appearance.
Curly and wavy hair usually gives superior results more easily in hair transplantation because a single curly hair has a tendency to curl on itself and covers more scalp than straight hair be it fine or course. Straight hair tends to lie against the scalp, thus providing a less dense appearance than curly or wavy hair. The closer the hair color is to the skin color, the better the appearance of coverage . For example, African hair is dark and very curly and provides the least contrast against various shades of dark skin. This will produce the best hair transplant results visually. Fair-haired men (blondes) with a light complexion also have a low contrast between hair and skin shades. This too can produce excellent results. Asian men however, with dark straight hair and light or beige complexions have a higher contrast between hair and skin, and usually pose the most challenges in hair transplantation. However, excellent results can be achieved by a highly skilled surgeon and team
It is imperative that the doctor considers the patient's future hair loss pattern and rate of change while designing the hair transplant procedure. It is important to remember that a natural hairline will vary from person to person. When a doctor chooses the recipient sites for hairline placement, several things should be taken into account - the shape of the face, the age of the patient, and the prognoses of future hair loss.
The crown of the head should never be transplanted unless the patient is older with stabilized hair loss (which is difficult to gauge). The front and the top of the head should be the areas considered in a hair transplant. This is the area that frames the face and makes the most dramatic change in one's appearance.
While losing a little off the top isn’t the social exile that it once was, the experience of hair loss is still stressful and frustrating for most people.
About 70 percent of men and 40 percent of women go through some degree of hair thinning as they age, almost usually as a result of androgenic alopecia (AGA), otherwise known as male or female pattern baldness. Though a number of products and treatments currently exist to fight back against hair loss, a so-called permanent "cure" would probably be one of the most exciting scientific discoveries to come along in a long time, right behind fat-free bacon and unlosable house keys. But is such a cure actually even possible? And if so, just how far from it are we?
1.HAIR TODAY, GONE TOMORROW
By conventional standards, the current line of hair loss treatments are pretty damneffective, though ultimately limited in their capabilities. Finasteride (Propecia) and Minoxidil (Rogaine) are very safe medications that significantly boost and even regenerate our noggin’s capacity for hair growth.
For the short primer: Hair continuously grows out of a single follicle for a period of about four years, all the while being nourished by surrounding cells. The follicle then undergoes a short hibernation phase of about three months, recuperates, and sheds the current hair strand attached to it before starting production back up. At any one time, about 10 percent of our follicles are in that resting state while the rest are happily pumping out luscious tubes of keratin.
However, the cycle can be interrupted or made shorter by a number of things, including when blood levels of the androgen Dihydrotestosterone (DHT) are too high, such as with AGA, or when the immune system is mistakenly compelled to attack the follicle, such as with alopecia areata (AA). It can also be permanently shut down when follicles are damaged beyond repair (we’re born with all the hair follicles we’ll ever have, so once one is taken out of commission, that’s that).
Minoxidil circumvents hair loss largely by increasing blood flow (and nutrition) to the follicles, though it’s also believed to return some dormant follicles to a healthy state of growth. Finasteride, on the other hand, is a DHT inhibitor and restores a degree of normal function to the follicles. But both treatments need to be applied daily to work; have a limit to the amount of hair they can restore (they won’t work on permanently damaged follicles), and lose their effectiveness over time for a subset of users (Dutasteride, another more potent but off label DHT inhibitor, faces the same limitation).
Hair transplantation, where productive follicles from the rest of the head or body are seeded into the balding areas, is a more permanent option. Far from the old perception of fake-looking hair grafts, these techniques have become very good at replicating "natural" hair. In recent years, we’ve seen the advent of robotic technologies that aid the surgeon in precisely extracting and transplanting follicle grafts with minimal scarring. But these surgeries are plenty expensive, costing upwards of $10,000, can only shift around the amount of total hair you have, and don’t stop additional hair loss.
Other treatments, like low-light laser therapy, or nutritional supplements, have the barest of evidence or plausibility supporting their use.
Though low-light laser therapies like the above have become popular, there's little proof showing that it can combat hair loss.Journal Sentinel/Gary Porter
Despair not though, embarrassed cap-wearing readers. As it turns out, there might actually be a bona-fide cure for hair loss already out there. Kind of.
About this time last year, the news was abuzz with the story of 25-year old Kyle Rhodes, a man whose head had become entirely bald, eyelashes included, because of his alopecia areata, first diagnosed when he was two. Like Lazarus rising out of a beauty salon, though, once Rhodes was treated with Xeljanz (tofacitinib), a drug ordinarily used for rheumatoid arthritis, his hair grew back after a scant eight months.
Kyle Rhodes' hair loss was completely reversed by the drug tofacitinib, but is it really a cure for baldness?Yale University
Funnily enough, his dermatologist, Dr. Brett King of Yale University, only prescribed the medication to help with Rhodes’ severe psoriasis, also an off-label use for the Pfizer-owned drug. "I was ecstatic," King told CNN. "I was truly overjoyed for him." He later published a study documenting Rhode’s hair recovery in the Journal of Investigative Dermatology.
"The results are exactly what we hoped for," King said in a statement released by the university. "This is a huge step forward in the treatment of patients with this condition. While it’s one case, we anticipated the successful treatment of this man based on our current understanding of the disease and the drug. We believe the same results will be duplicated in other patients, and we plan to try."
That same year, researchers in Nature Medicineannounced their own hair miracle, as they reported that an oral preparation of the bone marrow cancer drug ruxolitinib had restored more than half of the hair lost by three balding AA patients after five months of treatment, validating their earlier animal studies.
Miracles rarely come without some caveats though. The drugs likely worked to reverse hair loss because of their immunosuppressive effects on the body, with both drugs belonging to a new class of drugs known as JAK inhibitors. At the time, neither Rhodes nor the patients in the Nature study reported any adverse effects, but it’s known that sustained use of these sorts of drugs can have severe drawbacks like an increased risk of infection — as anyone who has undergone chemotherapy can attest to.
It also isn’t known whether taking someone off these drugs will, like Rogaine, result in the hair falling back out yet. In a follow-up interview with WebMD, the authors of the Nature study explained that out of the dozen people they treated with ruxolitinib, only six out of nine experienced the miraculous hair growth they first reported (the last three hadn’t been on the treatment long enough to conclude anything at that time). Being a recent invention, these drugs would be also fairly expensive to regularly prescribe.
Some of these concerns can be mitigated should a JAK inhibitor ever be made available in topical form. At the time of his study, King hoped to pursue a clinical trial using a cream version of tofacitinib. And as of last October, the Natureresearchers were eagerly looking to evaluate other JAK inhibitors in a placebo-controlled study. "Patients with alopecia areata are suffering profoundly, and these findings mark a significant step forward for them. The team is fully committed to advancing new therapies for patients with a vast unmet need," said study author Dr. Angela M. Christiano, professor in the Departments of Dermatology and of Genetics and Development at Columbia University Medical Center, in a statement.
Unfortunately, probably the biggest sticking point to these treatments is that they would likely do nothing for the majority of hair loss sufferers. AA, like rheumatoid arthritis and psoriasis, is an autoimmune disorder, and the mechanism by which baldness happens in these people is different than what causes AGA — though it would certainly be a great boon to the approximately four million people in America suffering from AA.
No, to permanently cure baldness will undoubtedly take a much more radical approach.
The major stumbling block to any hair loss cure is in restoring full functionality to our follicles, even those which have permanently become a Nair’d tundra. None of the current or proposed treatments we have available can pull that latter trick off.
Many researchers believe that the only way around this is to create new cells from scratch that stimulate hair growth for us, via stem cell therapy. Though stem cells, undifferentiated cells that can become a variety of specific cells, has been lauded as a potential means of regenerating organs or turning back the wheels of time, there’s logically no reason why they couldn’t also be turned into hair restorers.
Earlier this year, the authors of a PLOS-One study published this January may have made a giant leap in understanding how to accomplish that goal. From human pluripotent (embryonic) stem cells, they created cells that resembled dermal papilla cells, which reside underneath and regulate our follicles, and grafted them into the skin of albino mice. They discovered that these cells were able to stimulate hair growth.
Though it looks like razor stubble, the hair seen here, stimulated by bioengineered stem cells, might someday prove to be the cure to hair loss.Sanford-Burnham Medical Research Institute
What made their results particularly compelling was the fact that earlier attempts to use ordinary dermal papilla cells in grafting have come up short, due to their hair-simulating ability quickly fading away once removed from the body. It’s a shortcoming that the researchers believed they avoided by forcing the stem cells to pass through an additional transformation into a precursor stage of neural crest cells before finally becoming dermal papilla cells.
"Our stem cell method provides an unlimited source of cells from the patient for transplantation and isn't limited by the availability of existing hair follicles," said study author Dr. Alexey Terskikh, associate professor in the Development, Aging, and Regeneration Program at Sanford-Burnham University, in a statement at the time.
Though the research is only in the beginning stages, it "represents the first step towards development of a cell-based treatment for people with hair loss diseases," according to the authors.
"Our next step is to transplant human dermal papilla cells derived from human pluripotent stem cells back into human subjects," said Terskikh. "We are currently seeking partnerships to implement this final step."